Position in VTRS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$40,499,637
+$11,305,878 QoQ
Shares Held
2,550,355
+18.0% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#53
of 1,020 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARGENT CAPITAL MANAGEMENT LLC holds $43,594,031 across 2 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (92.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
2,550,355 | $40,499,637 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
18,360 | $3,094,394 |
All Filings in VTRS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,499,637 | 2,550,355 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $29,193,759 | 2,160,900 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||